[go: up one dir, main page]

NO20005556L - PTH 2 reseptor-selektive forbindelser - Google Patents

PTH 2 reseptor-selektive forbindelser

Info

Publication number
NO20005556L
NO20005556L NO20005556A NO20005556A NO20005556L NO 20005556 L NO20005556 L NO 20005556L NO 20005556 A NO20005556 A NO 20005556A NO 20005556 A NO20005556 A NO 20005556A NO 20005556 L NO20005556 L NO 20005556L
Authority
NO
Norway
Prior art keywords
pth
abnormal
selective compounds
receptor selective
functions
Prior art date
Application number
NO20005556A
Other languages
English (en)
Norwegian (no)
Other versions
NO20005556D0 (no
Inventor
Michael Chorev
Zheng Xin Dong
Michael Rosenblatt
Original Assignee
Sod Conseils Rech Applic
Beth Israel Hospital
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sod Conseils Rech Applic, Beth Israel Hospital filed Critical Sod Conseils Rech Applic
Publication of NO20005556D0 publication Critical patent/NO20005556D0/no
Publication of NO20005556L publication Critical patent/NO20005556L/no

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/575Hormones
    • C07K14/635Parathyroid hormone, i.e. parathormone; Parathyroid hormone-related peptides
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Endocrinology (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Zoology (AREA)
  • Toxicology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
NO20005556A 1998-05-05 2000-11-03 PTH 2 reseptor-selektive forbindelser NO20005556L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US7295698A 1998-05-05 1998-05-05
PCT/US1999/009521 WO1999057139A2 (en) 1998-05-05 1999-05-03 Pth2 receptor selective compounds

Publications (2)

Publication Number Publication Date
NO20005556D0 NO20005556D0 (no) 2000-11-03
NO20005556L true NO20005556L (no) 2001-01-03

Family

ID=22110801

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20005556A NO20005556L (no) 1998-05-05 2000-11-03 PTH 2 reseptor-selektive forbindelser

Country Status (12)

Country Link
US (2) US7531621B1 (es)
EP (1) EP1075491B1 (es)
JP (1) JP4460157B2 (es)
AT (1) ATE392431T1 (es)
AU (1) AU3673699A (es)
CA (1) CA2327509A1 (es)
DE (1) DE69938548T2 (es)
ES (1) ES2302374T3 (es)
HU (1) HUP0300891A2 (es)
NO (1) NO20005556L (es)
PL (1) PL344645A1 (es)
WO (1) WO1999057139A2 (es)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN100335501C (zh) 1996-09-26 2007-09-05 中外制药株式会社 抗人副甲状腺激素相关蛋白的抗体
CN1329080C (zh) 1997-05-15 2007-08-01 中外制药株式会社 恶病质的治疗剂
TWI255718B (en) 1999-07-02 2006-06-01 Chugai Pharmaceutical Co Ltd Ameliorative agent for low vasopressin concentration
WO2001002011A1 (fr) * 1999-07-02 2001-01-11 Chugai Seiyaku Kabushiki Kaisha REMEDES CONTRE LES MALADIES CAUSEES PAR PTH OU PTHrP
EP1987842A1 (en) 2000-04-28 2008-11-05 Chugai Seiyaku Kabushiki Kaisha Cell proliferation inhibitor
AU2001292905A1 (en) * 2000-09-19 2002-04-02 Curagen Corporation Method of identifying osteoregenerative agents using differential gene expression
WO2004071396A2 (en) * 2003-02-17 2004-08-26 Bayer Healthcare Ag Diagnostics and therapeutics for diseases associated with parathyroid hormone receptor 2 (pthr2)
EA014696B1 (ru) 2006-10-13 2010-12-30 Эли Лилли Энд Компани Пэгилированный паратиреоидный гормон в качестве модулятора рецептора паратиреоидного гормона и его применение
CA3017668C (en) * 2007-08-01 2021-11-09 The General Hospital Corporation Screening methods using g-protein coupled receptors and related compositions
KR101900078B1 (ko) 2010-05-13 2018-09-18 더 제너럴 하스피탈 코포레이션 부갑상선 호르몬 아날로그 및 그의 용도

Family Cites Families (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5001223A (en) * 1987-05-26 1991-03-19 Merck & Co., Inc. Parathyroid hormone antagonists with enhanced metabolic properties
EP0293158A3 (en) 1987-05-26 1990-05-09 Merck & Co. Inc. Parathyroid hormone antagonists
US5527772A (en) 1987-10-20 1996-06-18 Holick; Michael F. Regulation of cell proliferation and differentiation using peptides
EP0341962B1 (en) 1988-05-09 1995-03-15 Merck & Co. Inc. Humoral hypercalcemic factor antagonists
US4968669A (en) 1988-05-09 1990-11-06 Merck & Co., Inc. Parathyroid hormone antagonists
CA2040264A1 (en) 1990-04-12 1991-10-13 Tatsuhiko Kanmera Parathyroid hormone antagonists
US5093233A (en) 1990-04-25 1992-03-03 Merck & Co., Inc. Antagonists with position 13 modification
US5087562A (en) 1990-04-25 1992-02-11 Merck & Co., Inc. Humoral hypercalcemic factor antagonists with modification at position 13 . . .
US5149779A (en) 1990-07-26 1992-09-22 Merck & Co., Inc. Humoral hypercalcemic factor antagonists
JPH0532696A (ja) 1990-09-28 1993-02-09 Takeda Chem Ind Ltd 副甲状腺ホルモン誘導体
WO1992011286A1 (en) * 1990-12-21 1992-07-09 Allelix Biopharmaceuticals Inc. Oxidation resistant variants of parathyroid hormone
DE4203040A1 (de) 1992-02-04 1993-08-05 Boehringer Mannheim Gmbh Neue parathormonfragmente, deren herstellung und diese enthaltende arzneimittel
US5589452A (en) 1992-07-14 1996-12-31 Syntex (U.S.A.) Inc. Analogs of parathyroid hormone and parathyroid hormone related peptide: synthesis and use for the treatment of osteoporosis
AU672790B2 (en) 1992-07-15 1996-10-17 Novartis Ag Variants of parathyroid hormone and its fragments
CA2126299C (en) * 1994-06-20 2000-12-12 Gordon E. Willick Parathyroid hormone analogues for the treatment of osteoporosis
US5747456A (en) * 1994-12-19 1998-05-05 Beth Israel Deaconess Medical Center Continuous low-dose administration of parathyroid hormone or its agonist
US5717062A (en) * 1995-06-07 1998-02-10 Beth Israel Hospital Association Cyclic analogs of PTH and PTHrP
US5955574A (en) * 1995-07-13 1999-09-21 Societe De Conseils De Recherches Et D'applications Scientifiques, S.A. Analogs of parathyroid hormone
US5723577A (en) * 1995-07-13 1998-03-03 Biomeasure Inc. Analogs of parathyroid hormone
US5969095A (en) 1995-07-13 1999-10-19 Biomeasure, Inc. Analogs of parathyroid hormone
JP3259011B2 (ja) * 1995-08-02 2002-02-18 ミヤチテクノス株式会社 インバータ式抵抗溶接制御方法及び装置
WO1998004591A1 (en) 1996-07-31 1998-02-05 The General Hospital Corporation Novel parathyroid hormone-related peptide analogs

Also Published As

Publication number Publication date
JP2002513801A (ja) 2002-05-14
NO20005556D0 (no) 2000-11-03
ES2302374T3 (es) 2008-07-01
EP1075491B1 (en) 2008-04-16
DE69938548T2 (de) 2009-06-18
ATE392431T1 (de) 2008-05-15
WO1999057139A2 (en) 1999-11-11
JP4460157B2 (ja) 2010-05-12
CA2327509A1 (en) 1999-11-11
AU3673699A (en) 1999-11-23
PL344645A1 (en) 2001-11-19
US20090226477A1 (en) 2009-09-10
DE69938548D1 (de) 2008-05-29
HUP0300891A2 (hu) 2003-07-28
EP1075491A2 (en) 2001-02-14
WO1999057139A3 (en) 2000-02-03
US7531621B1 (en) 2009-05-12

Similar Documents

Publication Publication Date Title
NO20005556L (no) PTH 2 reseptor-selektive forbindelser
NO20055863L (no) W-karboksyarylsubstituerte difenylureaforbindelser som raf-kinaseinhibitorer
JO2359B1 (en) Benzathene derivatives as agents for modulation of GABA A receptor
AU3652102A (en) Compounds and their uses
WO2002022627A3 (en) Ligands for metabotropic glutamate receptors
YU33802A (sh) Policikloalkilpurini kao antagonisti adenozinskih receptora
ATE256671T1 (de) 2-phenyl-substituierte 1-(n-phenylaminoalkyl)- piperazin-derivate
DK1090029T3 (da) 14,15-Cyclopropansteroider fra 19-norandrostan-rækken, fremgangsmåde til deres fremstilling, og farmaceutiske præparater indeholdende disse forbindelser
BRPI0517039A (pt) método de flexão de materiais folha e respectiva folha
BR9609413A (pt) Formulações de dieta e farmacêuticas para a profilaxia e o tratamento de distúrbios gastrintestinais
RO118870B1 (ro) Monometansulfonat de acid (e)-alfa-[2-n-butil-1-[(4-carboxifenil)metil]-1h-imidazol-5-il]metilen-2-tiofenpropionic, procedee de preparare şi compoziţii farmaceutice
BRPI0411699A (pt) compostos para uso como substáncia terapeuticamente ativa; método para o tratamento e/ou profilaxia de doenças que estão associadas à modulação de receptores cb1 e uso destes compostos
MX360150B (es) Antagonista del receptor de angiotensina ii para la prevencion o el tratamiento de enfermedades generalizadas en gatos.
SE0201448L (sv) Förfarande för att reducera metanbildningen från matspjälkningsaktiviteter hos djur
DK1789019T3 (da) Pulvere indeholdende hidtil ukendte oligosaccharidblandinger og fremgangsmåder til fremstilling af disse
MY129668A (en) Use of cgrp antagonists and cgrp release inhibitors for combating menopausal hot flushes
GB9815618D0 (en) Treatment of dyskinesia
NO943133D0 (no) Benzodiazepinderivater egnet til bruk som CCK-reseptorantagonister
ID27771A (id) Turunan triazol-piridazin tersubstitusi, komposisi farmasi yang dibuat dari bahan itu
WO1999029308A3 (de) Methode zur bekämpfung der fettleibigkeit
NO20022471L (no) Kontinuerlig fremgangsmåte for produksjon av individuelle flak for en kontinuerlig bane
NO20014961L (no) Integrin-reseptor-ligander
TW200505906A (en) Selective mmp-13 inhibitors
SE9702794D0 (sv) New compounds
DK1014789T3 (da) Pressede chloramin-T-tabletter og fremgangsmåde til fremstilling heraf

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application